Presented at ATS 2019:
- The use of the AeroChamber Plus* Flow-Vu* VHC maximized the lung delivery of MDI medication, even after considerable inhalation delays.
- VHC use significantly reduced the amount of medication deposited in the oropharynx.
- When the MDI is used alone (without a VHC) it is important that actuation of the inhaler coincides with inhalation since even a 1-second delay can reduce medication delivery to the lungs by 80%.